Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base | Zendy

Vivek Verma | Zendy; Adams K. Appiah | Zendy; Tim Lautenschlaeger | Zendy; Sebastian Adeberg | Zendy; Charles B. Simone | Zendy; Chi Lin | Zendy

Open Access

Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base

Author(s) -

Vivek Verma,

Adams K. Appiah,

Tim Lautenschlaeger,

Sebastian Adeberg,

Charles B. Simone,

Chi Lin

Publication year - 2018

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo.2018.01.15

Subject(s) - medicine , chemoradiotherapy , proportional hazards model , cancer registry , cancer , population , radiation therapy , logistic regression , survival analysis , oncology , chemotherapy , database , surgery , computer science , environmental health

Current guidelines recommend chemotherapy (CT) with or without radiotherapy (RT) for unresected intrahepatic cholangiocarcinoma (IC). Although there is currently lack of consensus, previous smaller studies have illustrated the efficacy of local therapy for this population. This investigation evaluated outcomes of chemoradiotherapy (CRT) versus CT alone in unresected IC using a large, contemporary national database.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research